Brief: Aerovate Therapeutics Declares Special Cash Dividend In Connection With The Proposed Merger With Jade Biosciences
Aerovate Therapeutics Inc AVTE.O: AEROVATE THERAPEUTICS DECLARES SPECIAL CASH DIVIDEND IN CONNECTION WITH THE PROPOSED MERGER WITH JADE BIOSCIENCES AEROVATE THERAPEUTICS INC: AGGREGATE CASH DIVIDEND OF $69.6 MILLION, OR AN ESTIMATED $2.40 PER SHARE AEROVATE THERAPEUTICS INC: CASH DIVIDEND WILL BE AN AGGREGATE OF $69.6 MILLION, OR AN ESTIMATED $2.40 PER SHARE Source text: ID:nPnby2f62a Further company coverage: AVTE.O
Recent news on Jade Biosciences
See all newsBrief: Jade Biosciences Announces Preclinical Data Characterizing Jade301, A Potentially Best-In-Class, Half-Life-Extended Anti-Ifn-Β Monoclonal Antibody In Development For Dermatomyositis, At Eadv 2026
U.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public Storage
Jade Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Jade Biosciences Q2 net loss widens as costs rise
Brief: Jade Biosciences, Inc Q2 Cash & Investments USD 461.2 Million